Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04852887
Title De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) (DEBRA)
Acronym DEBRA
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors NRG Oncology
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.